Effect of aging on immunogenicity and efficacy of inactivated influenza vaccines in cotton rats Sigmodon hispidus

References

• Thompson WW, Shay DK, Weintraub E, Brammer L, Cox N, Anderson LJ, Fukuda K. Mortality associated with influenza and respiratory syncytial virus in the United States. JAMA. 2003;289(2):179–86. doi:10.1001/jama.289.2.179. PMID: 12517228
   PubMed Web of Science ®Google Scholar
• Schanzer DL, Tam TW, Langley JM, Winchester BT. Influenza-attributable deaths, Canada 1990-1999. Epidemiol Infect. 2007;135(7):1109–16. doi:10.1017/S0950268807007923. PMID: 17306052 PMCID: PMC2870678
   PubMed Web of Science ®Google Scholar
• CDC 2016-2017 report. [accessed 2019 Aug 8]. https://www.cdc.gov/flu/professionals/vaccination/ effectiveness-year/2016-2017.html
   Google Scholar
• Zhou H, Thompson WW, Viboud CG, Ringholz CM, Cheng PY, Steiner C, Abedi GR, Anderson LJ, Brammer L, Shay DK. Hospitalizations associated with influenza and respiratory syncytial virus in the United States, 1993-2008. Clin Infect Dis. 2012;54(10):1427–36. doi:10.1093/cid/cis211. PMID: 22495079 PMCID: PMC3334364
   PubMed Web of Science ®Google Scholar
• Langmuir AD, Henderson DA, Serfling RE. The epidemiological basis for the control of influenza. Am J Public Health Nations Health. 1964;54(4):563–71. doi:10.2105/ajph.54.4.563. PMID: 14136320 PMCID: PMC1254817.
   PubMed Web of Science ®Google Scholar
• Grohskopf LA, Sokolow LZ, Broder KR, Walter EB, Fry AM, Jernigan DB. Prevention and control of seasonal influenza with vaccines: recommendations of the advisory committee on immunization practices-United States, 2018-19 Influenza Season. MMWR Recomm Rep. 2018;67(3):1–20. doi:10.15585/mmwr.rr6703a1. PMID: 30141464 PMCID: PMC6107316
   PubMed Web of Science ®Google Scholar
• NVIC (National Vaccine Information Center). What is the history of influenza vaccine use in America? 2019 [accessed 2019 Aug 8]. https://www.nvic.org/vaccines-and-diseases/influenza/vaccine-history.aspx
   Google Scholar
• Goodwin K, Viboud C, Simonsen L. Antibody response to influenza vaccination in the elderly: a quantitative review. Vaccine. 2006;24(8):1159–69. doi:10.1016/j.vaccine.2005.08.105. PMID: 16213065
   PubMed Web of Science ®Google Scholar
• Sasaki S, Sullivan M, Narvaez CF, Holmes TH, Furman D, Zheng NY, Nishtala M, Wrammert J, Smith K, James JA, et al. Limited efficacy of inactivated influenza vaccine in elderly individuals is associated with decreased production of vaccine-specific antibodies. J Clin Invest. 2011;121(8):3109–19. doi:10.1172/JCI57834. PMID: 21785218 PMCID: PMC3148747
   PubMed Web of Science ®Google Scholar
• Falsey AR, Treanor JJ, Tornieporth N, Capellan J, Gorse GJ. Randomized, double-blind controlled phase 3 trial comparing the immunogenicity of high-dose and standard-dose influenza vaccine in adults 65 years of age and older. J Infect Dis. 2009;200(2):172–80. doi:10.1086/599790. PMID: 19508159
   PubMed Web of Science ®Google Scholar
• DiazGranados CA, Dunning AJ, Kimmel M, Kirby D, Treanor J, Collins A, Pollak R, Christoff J, Earl J, Landolfi V, et al. Efficacy of high-dose versus standard-dose influenza vaccine in older adults. N Engl J Med. 2014;371(7):635–45. doi:10.1056/NEJMoa1315727. PMID: 25119609
   PubMed Web of Science ®Google Scholar
• Frey SE, Reyes MR, Reynales H, Bermal NN, Nicolay U, Narasimhan V, Forleo-Neto E, Arora AK. Comparison of the safety and immunogenicity of an MF59®-adjuvanted with a non-adjuvanted seasonal influenza vaccine in elderly subjects. Vaccine. 2014;32(39):5027–34. doi:10.1016/j.vaccine.2014.07.013. PMID: 25045825
   PubMed Web of Science ®Google Scholar
• McElhaney JE, Coler RN, Baldwin SL. Immunologic correlates of protection and potential role for adjuvants to improve influenza vaccines in older adults. Expert Rev Vaccines. 2013 Jul;12(7):759–66. doi:10.1586/14760584.2013.811193.
   PubMed Web of Science ®Google Scholar
• Trucchi C, Paganino C, Orsi A, De Florentiis D, Ansaldi F. Influenza vaccination in the elderly: why are the overall benefits still hotly debated? J Prev Med Hyg. 2015;56(1):E37–E43. PMID: 26789831 PMCID: PMC4718343
   PubMedGoogle Scholar
• Treanor JJ, Talbot HK, Ohmit SE, Coleman LA, Thompson MG, Cheng PY, Petrie JG, Lofthus G, Meece JK, Williams JV, et al. Effectiveness of seasonal influenza vaccines in the United States during a season with circulation of all three vaccine strains. Clin Infect Dis. 2012;55(7):951–59. doi:10.1093/cid/cis574. PMID: 22843783 PMCID: PMC3657521
   PubMed Web of Science ®Google Scholar
• McLean HQ, Thompson MG, Sundaram ME, Kieke BA, Gaglani M, Murthy K, Piedra PA, Zimmerman RK, Nowalk MP, Raviotta JM, et al. Influenza vaccine effectiveness in the United States during 2012-2013: variable protection by age and virus type. J Infect Dis. 2015;211(10):1529–40. doi:10.1093/infdis/jiu647. PMID: 25406334 PMCID: PMC4407759
   PubMed Web of Science ®Google Scholar
• Gaglani M, Pruszynski J, Murthy K, Clipper L, Robertson A, Reis M, Chung JR, Piedra PA, Avadhanula V, Nowalk MP, et al. Influenza vaccine effectiveness against 2009 Pandemic Influenza A(H1N1) virus differed by vaccine type during 2013-2014 in the United States. J Infect Dis. 2016;213(10):1546–56. doi:10.1093/infdis/jiv577. PMID: 26743842 PMCID: PMC4837903
   PubMed Web of Science ®Google Scholar
• Belongia EA, Simpson MD, King JP, Sundaram ME, Kelley NS, Osterholm MT, McLean HQ. Variable influenza vaccine effectiveness by subtype: a systematic review and meta-analysis of test-negative design studies. Lancet Infect Dis. 2016;16(8):942–51. doi:10.1016/S1473-3099(16)00129-8. PMID: 27061888
   PubMed Web of Science ®Google Scholar
• Russell K, Chung JR, Monto AS, Martin ET, Belongia EA, McLean HQ, Gaglani M, Murthy K, Zimmerman RK, Nowalk MP, et al. Influenza vaccine effectiveness in older adults compared with younger adults over five seasons. Vaccine. 2018;36(10):1272–78. doi:10.1016/j.vaccine.2018.01.045. PMID: 29402578 PMCID: PMC5812289
   PubMed Web of Science ®Google Scholar
• Kissling E, Valenciano M, Falcao J, Larrauri A, Widgren K, Pitigoi D, Oroszi B, Nunes B, Savulescu C, Mazick A, et al. “I-MOVE” towards monitoring seasonal and pandemic influenza vaccine effectiveness: lessons learnt from a pilot multi-centric case-control study in Europe, 2008-9. Euro Surveill. 2009;14(44):pii: 19388. Erratum in: Euro Surveill. 2009;14(45)pii: 19399. PMID: 19941774
   Google Scholar
• Mbawuike IN, Wyde PR, Anderson PM. Enhancement of the protective efficacy of inactivated influenza A virus vaccine in aged mice by IL-2 liposomes. Vaccine. 1990 Aug;8(4):347–52. doi:10.1016/0264-410X(90)90093-2. PMID: 1697721.
   PubMed Web of Science ®Google Scholar
• McDonald JU, Zhong Z, Groves HT, Tregoning JS. Inflammatory responses to influenza vaccination at the extremes of age. Immunology. 2017 Aug;151(4):451–63. doi:10.1111/imm.12742. PMID: 28375554 PMCID: PMC5506419.
   PubMed Web of Science ®Google Scholar
• Baldwin SL, Hsu FC, Van Hoeven N, Gage E, Granger B, Guderian JA, Larsen SE, Lorenzo EC, Haynes L, Reed SG, et al. Improved immune responses in young and aged mice with adjuvanted vaccines against H1N1 influenza infection. Front Immunol. 2018 Feb 19;9:295. doi:10.3389/fimmu.2018.00295. PMID: 29515589 PMCID: PMC5826078.
   PubMed Web of Science ®Google Scholar
• Vassilieva EV, Taylor DW, Compans RW. Combination of STING pathway agonist with saponin is an effective adjuvant in immunosenescent mice. Front Immunol. 2019 Dec 23;10:3006. doi:10.3389/fimmu.2019.03006. eCollection 2019.
   PubMed Web of Science ®Google Scholar
• Ramirez A, Co M, Mathew A. CpG improves influenza vaccine efficacy in young adult but not aged mice. PLoS One. 2016 Mar 2;11(3):e0150425. doi:10.1371/journal.pone.0150425. PMID: 26934728 PMCID: PMC4774967.
   PubMed Web of Science ®Google Scholar
• Gagneux P, Cheriyan M, Hurtado-Ziola N, van der Linden EC, Anderson D, McClure H, Varki A, Varki NM. Human-specific regulation of alpha 2-6-linked sialic acids. J Biol Chem. 2003;278(48):48245–50. doi:10.1074/jbc.M309813200. PMID: 14500706.
   PubMed Web of Science ®Google Scholar
• Ibricevic A, Pekosz A, Walter MJ, Newby C, Battaile JT, Brown EG, Holtzman MJ, Brody SL. Influenza virus receptor specificity and cell tropism in mouse and human airway epithelial cells. J Virol. 2006;80(15):7469–80. doi:10.1128/JVI.02677-05. PMID: 16840327 PMCID: PMC1563738.
   PubMed Web of Science ®Google Scholar
• Xu Q, Wang W, Cheng X, Zengel J, Jin H. Influenza H1N1 A/Solomon Island/3/06 virus receptor binding specificity correlates with virus pathogenicity, antigenicity, and immunogenicity in ferrets. J Virol. 2010 May;84(10):4936–45. doi:10.1128/JVI.02489-09. PMID: 20200248 PMCID: PMC2863823.
   PubMed Web of Science ®Google Scholar
• Belser JA, Katz JM, Tumpey TM. The ferret as a model organism to study influenza A virus infection. Dis Model Mech. 2011 Sep;4(5):575–79. doi:10.1242/dmm.007823. Epub 2011 Aug 2. PMID: 21810904 PMCID: PMC3180220.
   PubMed Web of Science ®Google Scholar
• Enkirch T, von Messling V. Ferret models of viral pathogenesis. Virology. 2015 May;479-480:259–70. doi:10.1016/j.virol.2015.03.017. Epub 2015 Mar 26. PMID: 25816764.
   PubMed Web of Science ®Google Scholar
• de Jong JC, Beyer WE, Palache AM, Rimmelzwaan GF, Osterhaus AD. Mismatch between the 1997/1998 influenza vaccine and the major epidemic A(H3N2) virus strain as the cause of an inadequate vaccine-induced antibody response to this strain in the elderly. J Med Virol. 2000 May;61(1):94–99. doi:10.1002/(SICI)1096-9071(200005)61:1<94::AID-JMV15>3.0.CO;2-C. PMID: 10745239.
   PubMed Web of Science ®Google Scholar
• Cobey S, Gouma S, Parkhouse K, Chambers BS, Ertl HC, Schmader KE, Halpin RA, Lin X, Stockwell TB, Das SR, et al. Poor immunogenicity, not vaccine strain egg adaptation, may explain the low H3N2 influenza vaccine effectiveness in 2012-2013. Clin Infect Dis. 2018 Jul 18;67(3):327–33. doi:10.1093/cid/ciy097. PMID: 29471464 PMCID: PMC6051447.
   PubMed Web of Science ®Google Scholar
• Kosikova M, Li L, Radvak P, Ye Z, Wan XF, Xie H. Imprinting of repeated influenza A/H3 exposures on antibody quantity and antibody quality: implications for seasonal vaccine strain selection and vaccine performance. Clin Infect Dis. 2018 Oct 30;67(10):1523–32. doi:10.1093/cid/ciy327. PMID: 29672713 PMCID: PMC6206119.
   PubMed Web of Science ®Google Scholar
• Bissel SJ, Carter CE, Wang G, Johnson SK, Lashua LP, Kelvin AA, Wiley CA, Ghedin E, Ross TM. Age-related pathology associated with H1N1 A/California/07/2009 influenza virus infection. Am J Pathol. 2019 Dec;189(12):2389–99. doi:10.1016/j.ajpath.2019.08.017. Epub 2019 Oct 1.
   PubMed Web of Science ®Google Scholar
• Ottolini MG, Blanco JCG, Eichelberger MC, Porter DD, Pletneva L, Richardson JY, Prince GA. The cotton rat provides a useful small-animal model for the study of influenza virus pathogenesis. J Gen Virol. 2005 Oct;86(Pt 10):2823–30. doi:10.1099/vir.0.81145-0. PMID: 16186238.
   PubMedGoogle Scholar
• Eichelberger MC. The cotton rat as a model to study influenza pathogenesis and immunity. Viral Immunol. 2007 Summer;20(2):243–49. doi:10.1089/vim.2007.0017. PMID: 17603841
   PubMed Web of Science ®Google Scholar
• Blanco JC, Pletneva LM, Wan H, Araya Y, Angel M, Oue RO, Sutton TC, Perez DR. Receptor characterization and susceptibility of cotton rats to avian and 2009 pandemic influenza virus strains. J Virol. 2013;87(4):2036–45. doi:10.1128/JVI.00638-12. PMID: 23192875 PMCID: PMC3571489
   PubMed Web of Science ®Google Scholar
• Ottolini M, Blanco J, Porter D, Peterson L, Curtis S, Prince G. Combination anti-inflammatory and antiviral therapy of influenza in a cotton rat model. Pediatr Pulmonol. 2003 Oct;36(4):290–94. doi:10.1002/ppul.10320. PMID: 12950040.
   PubMed Web of Science ®Google Scholar
• Yim K, Miles B, Zinsou R, Prince G, Boukhvalova M. Efficacy of trivalent inactivated influenza vaccines in the cotton rat Sigmodon hispidus model. Vaccine. 2012;30(7):1291–96. doi:10.1016/j.vaccine.2011.12.084. PMID: 22210139
   PubMed Web of Science ®Google Scholar
• Braun LE, Sutter DE, Eichelberger MC, Pletneva L, Kokai-Kun JF, Blanco JC, Prince GA, Ottolini MG. Co-infection of the cotton rat (Sigmodon hispidus) with Staphylococcus aureus and influenza A virus results in synergistic disease. Microb Pathog. 2007 Nov-Dec;43(5–6):208–16. doi:10.1016/j.micpath.2007.03.005. PMID: 17689046.
   PubMed Web of Science ®Google Scholar
• Curtis SJ, Ottolini MG, Porter DD, Prince GA. Age-dependent replication of respiratory syncytial virus in the cotton rat. Exp Biol Med (Maywood). 2002;227(9):799–802. doi:10.1177/153537020222700912. PMID: 12324660
   PubMed Web of Science ®Google Scholar
• Boukhvalova MS, Yim KC, Kuhn KH, Hemming JP, Prince GA, Porter DD, Blanco JC. Age-related differences in pulmonary cytokine response to respiratory syncytial virus infection: modulation by anti-inflammatory and antiviral treatment. J Infect Dis. 2007;195(4):511–18. doi:10.1086/510628. PMID: 17230410
   PubMed Web of Science ®Google Scholar
• Guichelaar T, Hoeboer J, Widjojoatmodjo MN, Reemers SS, van Els CA, Otten R, van Remmerden Y, Boes J, Luytjes W. Impaired immune response to vaccination against infection with human respiratory syncytial virus at advanced age. J Virol. 2014;88(17):9744–50. doi:10.1128/JVI.01101-14. PMID: 24920795 PMCID: PMC4136321
   PubMed Web of Science ®Google Scholar
• Guichelaar T, van Erp EA, Hoeboer J, Smits NAM, van Els CACM, Pieren DKJ, Luytjes W. Diversity of aging of the immune system classified in the cotton rat (Sigmodon hispidus) model of human infectious diseases. Dev Comp Immunol. 2018;82:39–48. doi:10.1016/j.dci.2017.12.026. PMID: 29305168.
   PubMed Web of Science ®Google Scholar
• Patel MC, Shirey KA, Boukhvalova MS, Vogel SN, Blanco JCG. Serum high-mobility-group box 1 as a biomarker and a therapeutic target during respiratory virus Infections. MBio. 2018;9(2). doi:10.1128/mBio.00246-18. PMID: 29535197 PMCID: PMC5850323
   Web of Science ®Google Scholar
• Prince GA, Curtis SJ, Yim KC, Porter DD. Vaccine-enhanced respiratory syncytial virus disease in cotton rats following immunization with Lot 100 or a newly prepared reference vaccine. J Gen Virol. 2001;82(Pt12):2881–88. doi:10.1099/0022-1317-82-12-2881. PMID: 11714962
   PubMedGoogle Scholar
• Boukhvalova MS, Yim KC, Prince GA, Blanco JC. Methods for monitoring dynamics of pulmonary RSV replication by viral culture and by real-time reverse transcription-PCR in vivo: detection of abortive viral replication. Curr Protoc Cell Biol. 2010;46(1). doi:10.1002/0471143030.cb2606s46. Chapter 26:Unit26.6;PMID: 20235102 PMCID: PMC3049332
   Google Scholar
• Olafsdottir TA, Alexandersson KF, Sveinbjornsson G, Lapini G, Palladino L, Montomoli E, Del Giudice G, Gudbjartsson DF, Jonsdottir I. Age and influenza-specific pre-vaccination antibodies strongly affect influenza vaccine responses in the icelandic population whereas disease and medication have small effects. Front Immunol. 2018;8. doi:10.3389/fimmu.2017.01872.
   PubMed Web of Science ®Google Scholar
• Jonges M, Liu WM, van der Vries E, Jacobi R, Pronk I, Boog C, Koopmans M, Meijer A, Soethout E. Influenza virus inactivation for studies of antigenicity and phenotypic neuraminidase inhibitor resistance profiling. J Clin Microbiol. 2010 Mar;48(3):928–40. doi:10.1128/JCM.02045-09.
   PubMed Web of Science ®Google Scholar
• Lee MS, Mahmood K, Adhikary L, August MJ, Cordova J, Cho I, Kemble G, Reisinger K, Walker RE, Mendelman PM. Measuring antibody responses to a live attenuated influenza vaccine in children. Pediatr Infect Dis J. 2004 Sep;23(9):852–56. doi:10.1097/01.inf.0000137566.87691.3b. PMID: 15361726.
   PubMed Web of Science ®Google Scholar
• Planty C, Mallett CP, Yim K, Blanco JC, Boukhvalova M, March T, van der Most R, Destexhe E. Evaluation of the potential effects of AS03-adjuvanted A(H1N1)pdm09 vaccine administration on the central nervous system of non-primed and A(H1N1)pdm09-primed cotton rats. Hum Vaccin Immunother. 2017;13(1):90–102. doi:10.1080/21645515.2016.1227518. PMID: 27629482 PMCID: PMC5287305
   PubMed Web of Science ®Google Scholar
• Gravenstein S, Davidson HE, Taljaard M, Ogarek J, Gozalo P, Han L, Mor V. Comparative effectiveness of high-dose versus standard-dose influenza vaccination on numbers of US nursing home residents admitted to hospital: a cluster-randomised trial. Lancet Respir Med. 2017;5(9):738–46. doi:10.1016/S2213-2600(17)30235-7. PMID: 28736045
   PubMed Web of Science ®Google Scholar
• Manzoli L, Ioannidis JP, Flacco ME, De Vito C, Villari P. Effectiveness and harms of seasonal and pandemic influenza vaccines in children, adults and elderly: a critical review and re-analysis of 15 meta-analyses. Hum Vaccin Immunother. 2012;8(7):851–62. doi:10.4161/hv.19917. PMID: 22777099 PMCID: PMC3495721
   PubMed Web of Science ®Google Scholar
• Govaert TM, Thijs CT, Masurel N, Sprenger MJ, Dinant GJ, Knottnerus JA. The efficacy of influenza vaccination in elderly individuals. A randomized double-blind placebo-controlled trial. JAMA. 1994;272(21):1661–65. doi:10.1001/jama.1994.03520210045030. PMID: 7966893.
   PubMed Web of Science ®Google Scholar
• Raymond DD, Stewart SM, Lee J, Ferdman J, Bajic G, Do KT, Ernandes MJ, Suphaphiphat P, Settembre EC, Dormitzer PR, et al. Influenza immunization elicits antibodies specific for an egg-adapted vaccine strain. Nat Med. 2016;22(12):1465–69. doi:10.1038/nm.4223. PMID: 27820604 PMCID: PMC5485662.
   PubMed Web of Science ®Google Scholar
• Zost SJ, Parkhouse K, Gumina ME, Kim K, Diaz Perez S, Wilson PC, Treanor JJ, Sant AJ, Cobey S, Hensley SE, et al. Contemporary H3N2 influenza viruses have a glycosylation site that alters binding of antibodies elicited by egg-adapted vaccine strains. Proc Natl Acad Sci U S A. 2017;114(47):12578–83. doi:10.1073/pnas.1712377114. PMID: 29109276 PMCID: PMC5703309.
   PubMed Web of Science ®Google Scholar
• Skowronski DM, Janjua NZ, De Serres G, Sabaiduc S, Eshaghi A, Dickinson JA, Fonseca K, Winter A-L, Gubbay JB, Krajden M, et al. Low 2012-13 influenza vaccine effectiveness associated with mutation in the egg-adapted H3N2 vaccine strain not antigenic drift in circulating viruses. PLoS One. 2014;9(3):e92153. doi:10.1371/journal.pone.0092153.
   PubMed Web of Science ®Google Scholar
• Rudenko LG, Arden NH, Grigorieva E, Naychin A, Rekstin A, Klimov AI, Donina S, Desheva J, Holman RC, DeGuzman A, et al. Immunogenicity and efficacy of Russian live attenuated and US inactivated influenza vaccines used alone and in combination in nursing home residents. Vaccine. 2000;19(2–3):308–18. doi:10.1016/s0264-410x(00)00153-5. PMID: 10930686
   PubMed Web of Science ®Google Scholar
• Bellei N, Carraro E, Perosa A, Watanabe A, Arruda E, Granato C, Skowronski DM, Janjua NZ, De Serres G, Sabaiduc S. Acute respiratory infection and influenza-like illness viral etiologies in Brazilian adults. J Med Virol. 2008;80(10):1824–27. doi:10.1002/jmv.21295. PMID: 18712837
   PubMed Web of Science ®Google Scholar
• Manzoli L, Salanti G, De Vito C, Boccia A, Ioannidis JP, Villari P. Immunogenicity and adverse events of avian influenza A H5N1 vaccine in healthy adults: multiple-treatments meta-analysis. Lancet Infect Dis. 2009;9(8):482–92. doi:10.1016/S1473-3099(09)70153-7. PMID: 19628173
   PubMed Web of Science ®Google Scholar
• Prieto-Lara E, Llanos-Méndez A. Safety and immunogenicity of prepandemic H5N1 influenza vaccines: a systematic review of the literature. Vaccine. 2010;28(26):4328–34. doi:10.1016/j.vaccine.2010.03.068. PMID: 20403350
   PubMed Web of Science ®Google Scholar
• Toapanta FR, Ross TM. Impaired immune responses in the lungs of aged mice following influenza infection. Respir Res. 2009 Nov 18;10(1):112. doi:10.1186/1465-9921-10-112.
   PubMedGoogle Scholar
• Schneider-Ohrum K, Giles BM, Weirback HK, Williams BL, DeAlmeida DR, Ross TM. Adjuvants that stimulate TLR3 or NLPR3 pathways enhance the efficiency of influenza virus-like particle vaccines in aged mice. Vaccine. 2011 Nov 8;29(48):9081–92. doi:10.1016/j.vaccine.2011.09.051.
   PubMed Web of Science ®Google Scholar
• Paquette SG, Huang SSH, Banner D, Xu L, Leόn A, Kelvin AA, Kelvin DJ. Impaired heterologous immunity in aged ferrets during sequential influenza A H1N1 infection. Virology. 2014 Sep;464-465:177–83. doi:10.1016/j.virol.2014.07.013.
   PubMed Web of Science ®Google Scholar